Table 4 Medium-late complications
From: Pelvic exenteration in gynecologic cancer: complications and oncological outcome
Readmission [n (%)] | 15 (65) |
Days after discharge [Mean ± SD (range)] | 102.4 ± 136.2 (10–515) |
Re- surgery [n (%)] | 7 (30) |
Transfusion [n (%)] | 9 (39) |
Circulatory event [n (%)] | |
Thromboembolism | 1 (4) |
Cardiovascular event | 0 (0) |
Urinary [n (%)] | |
No | 13 (57) |
Pyelonephritis | 6 (26) |
Fistula | 2 (9) |
Ureteral stricture | 7 (30) |
Bricker failure and reconstruction | 1 (4) |
Renal failure | 4 (17) |
Gastrointestinal [n (%)] | |
No | 15 (65) |
Paralytic ileus | 5 (22) |
Small bowel fistula/perforation | 4 (17) |
Eventration | 1 (4) |
Infectious [n (%)] | |
No | 13 (57) |
Abscess | 4 (17) |
Wound infection | 4 (17) |
Sepsis | 6 (26) |
Others [n (%)] | |
Acute limb ischemia | 1 (4) |
Coagulopathy | 1 (4) |
Septic shock | 1 (4) |
Abdominal cloaca (Both ureter and bowel fistula) | 1 (4) |
Clavien Dindo [Mean ± SD (range)] | |
Grade II | 1.4 ± 1.4 (0–4) |
Grade III | 1.1 ± 1.5 (0–6) |
Grade IV | 0.8 ± 0.9 (0–3) |
Patients with complications [n (%)] | |
Grade II | 15 (65) |
Grade III | 11 (48) |
Grade IV | 3 (13) |
Grade V | 2 (9) |